How AI Is Changing What Work Means
Summary
This episode examines the expanding role of AI in biotechnology, highlighting OpenAI’s acquisition of Orchestra Bio and Anthropic’s internal wet lab initiatives. The host analyzes the Citrini Research experiment, where a financial firm used Claude to design scorpion venom binders, illustrating how AI is enabling non-experts to tackle complex scientific problems. The discussion also covers Meta’s Muse app growth, Gemini’s integration into Android Auto, and recent financial disclosures from Anthropic and OpenAI.
Topics discussed
Intro: AI changing work and the scorpion venom story
Sponsors and show announcements
Meta Muse hits 10M downloads and retention analysis
The retention challenge for personal AI agents
Security flaw in Meta Muse sharing feature
Gemini Assistant upgrade in Android Auto
Anthropic financial leak: losses and compute spend
OpenAI fundraising race ahead of Anthropic IPO
Sponsor segments: KPMG, C-Data, Granola, Blitzy
Main topic: AI in biology and public sentiment
OpenAI acquires Orchestra Bio for drug discovery
Anthropic's internal wet lab and X-risk concerns
Citrini Research uses Claude to design scorpion antivenom
Skepticism and the bottleneck of physical validation
Will AI labs internalize scientific results?
Can curing diseases fix public opinion on AI?
How AI changes what we work on, not just how
Listen ad-free on Castria